<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1710222744
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CALCIUM FOLINATE 50MG-5ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FOLINIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        82.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HOSPIRA AUSTRALIA " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HOSPIRA AUSTRALIA 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2657]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pfizer Saudi Trading
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            HOSPIRA UK LIMITED
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        V03AF03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Calcium folinate is one of the B group of vitamins.</p><p>&nbsp;</p><p>Calcium Folinate Injection is used to reduce the side effects of other medicines (a group of medicines called folic acid antagonists).&nbsp; Examples of folic acid antagonists are:</p><ul><li>methotrexate (a medicine often used to treat cancer)</li><li>trimetrexate (an antibiotic and anti-cancer medicine)</li><li>trimethoprim (an antibiotic)</li><li>pyrimethamine (a medicine often used to treat malaria)</li></ul><p>&nbsp;</p><p>It may also be used to treat an overdose of these medicines.</p><p>&nbsp;</p><p>Calcium Folinate Injection may also be used to increase the effectiveness of the anti-cancer medicine fluorouracil.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Calcium Folinate Injection must not be injected intrathecally (into the spine).</strong></p><p><strong>&nbsp;</strong></p><p><strong>Do not use </strong><strong>Calcium Folinate Injection</strong></p><ul><li>if you have shown signs of hypersensitivity (severe allergy) to calcium folinate in the past</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a type of anaemia caused by too little vitamin B<sub>12</sub></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Tell your doctor if either of the above applies to you before this medicine is used.</p><p>&nbsp;</p><p><strong>Take special care with Calcium Folinate Injection</strong></p><p>If you are to receive calcium folinate and fluorouracil treatment at the same time take special care if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have had radiotherapy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have stomach or bowel trouble</p><p>&nbsp;</p><p>Tell your doctor if the above applies to you before this medicine is used.</p><p>&nbsp;</p><p>Special care is also needed if you are elderly and you are to receive calcium folinate and fluorouracil treatment at the same time.</p><p>&nbsp;</p><p><strong>Taking/using other medicines</strong></p><p>Special care is needed if you are taking/using other medicines as some could interact with Calcium Folinate Injection, for example:</p><ul><li>folic acid antagonists (see section 1 &lsquo;What Calcium Folinate is and what it is used for&rsquo; for examples of these medicines) - the effectiveness of these medicines will be reduced by calcium folinate</li><li>fluorouracil (anti-cancer medicine) &ndash; the effectiveness and side effects of this medicine will be increased by calcium folinate</li><li>medicines used to treat epilepsy (phenobarbitone, phenytoin, primidone or succinimides) &ndash; the effectiveness of these medicines may be reduced by calcium folinate.&nbsp; Your doctor may check blood levels of these medicines and change your dose to prevent increased convulsions (fits)</li></ul><p>&nbsp;</p><p>Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Tell your doctor if you are pregnant, trying to become pregnant or breast-feeding.</p><p>&nbsp;</p><p>It is unlikely that your doctor will ask you to take/use a folic acid antagonist or fluorouracil whilst you are pregnant or breast-feeding.&nbsp; However, if you have taken/used a folic acid antagonist whilst pregnant or breast-feeding, this medicine (calcium folinate) may be used to reduce its side effects.</p><p>&nbsp;</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p><strong>Calcium Folinate Injection contains sodium</strong></p><p>&nbsp;</p><p>Calcium folinate 50 mg/5 ml solution for injection contains 16.74 mg of sodium (main component of cooking/table salt) in each 5 ml vial. This is equivalent to 0.8% of the recommended maximum daily dietary intake of sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine may be given by injection (using a syringe) into muscle. Alternatively it may be given by injection or infusion (drip) into a vein. If it is given by infusion Calcium Folinate Injection will be diluted first.</p><p><strong>&nbsp;</strong></p><p><strong>Dose</strong></p><p>Your doctor will work out the correct dose of Calcium Folinate Injection for you and how often it must be given.&nbsp; It will depend upon the medical condition which is being treated.</p><p>&nbsp;</p><p><strong>If you are given too much or too little Calcium Folinate Injection</strong></p><p>This medicine will be given to you in a hospital, under the supervision of a doctor.&nbsp; It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Calcium Folinate Injection can cause side effects, although not everybody gets them.</p><p><br /><strong>Very rare: may affect up to 1 in 10,000 people</strong></p><ul><li>severe allergic reaction - you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint. This is a serious side effect. You may need urgent medical attention.</li></ul><p><strong>&nbsp;</strong></p><p><strong>Uncommon: may affect up to 1 in 100 people</strong></p><ul><li>fever</li></ul><p><strong>&nbsp;</strong></p><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><ul><li>an increase in convulsions (fits) in patients with epilepsy</li><li>depression</li><li>agitation</li><li>problems with the digestive system</li><li>difficulty sleeping (insomnia)</li></ul><p>&nbsp;</p><p><em>Combination therapy with 5-fluorouracil only: </em></p><p>If you receive calcium folinate in combination with an anticancer medicine containing fluoropyrimidines, it is more likely that you experience the following side effects of this other medicine:</p><p>&nbsp;</p><p><strong>Very common: may affect more than 1 in 10 people </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drying out which may be due to diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lining of the intestine and mouth (life-threatening conditions have occurred)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduction in the number of blood cells (including life-threatening conditions)</p><p>&nbsp;</p><p><strong>Common:</strong><strong> may affect up to 1 in 10 people</strong><strong> </strong></p><p>&bull; redness and swelling of the palms of the hands or the soles of the feet which may cause the skin to peel (hand-foot syndrome)</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data </strong></p><p>&bull; elevated ammonia level in the blood</p><p>&nbsp;</p><p>Your doctor may do tests to check for low levels of calcium in your blood.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>To Report side effects</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children</p><p>&nbsp;</p><p><strong>Expiry</strong></p><p>This medicine must not be used after the expiry date which is stated on the vial and carton after &#39;EXP&#39;.&nbsp; Where only a month and year is stated, the expiry date refers to the last day of that month.</p><p>&nbsp;</p><p><strong>Storage</strong></p><p>The vials should be stored in the outer carton, in order to protect from light, in a refrigerator.</p><p>&nbsp;</p><p><strong>Visible signs of deterioration</strong></p><p>Only clear, pale yellow solutions should be used. If cloudy in appearance or particles can be seen, the solution should be discarded.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is folinic acid. &nbsp;Each millilitre (ml) of solution contains 10 milligrams (mg) of folinic acid in the form of calcium folinate hydrate.</p><p>&nbsp;</p><p>The other ingredients are sodium chloride and Water for Injections. &nbsp;See section 2 &lsquo;Calcium Folinate Injection contains sodium&rsquo; for further information about the sodium content.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Calcium Folinate Injection is a clear, pale yellow solution for injection which comes in glass containers called vials. 

It is supplied in packs containing:
•	1 x 50 mg/5 ml vial

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing authorization holder:</strong></p><p>Hospira UK Ltd, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>Hospira Australia Pty Ltd 1-5, 7-23 and 25-39 Lexia Place MULGRAVE, VIC 3170, Australia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                May 2023.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&nbsp;ينتمي فولينات الكالسيوم لمجموعة فيتامينات ب.</p><p>&nbsp;</p><p dir="RTL">تُستخدم حقن فولينات الكالسيوم لتقليل الآثار الجانبية الخاصة بأدوية أخرى (مجموعة من الأدوية تُسمى مضادات حمض الفوليك).&nbsp; من أمثلة مضادات حمض الفوليك:</p><ul><li dir="RTL">ميثوتريكسات (دواء يُستخدم غالبًا لعلاج السرطان)</li><li dir="RTL">ترايميتريكسات (دواء مضاد حيوي ومضاد للسرطان)</li><li dir="RTL">تريميثوبريم (مضاد حيوي)</li><li dir="RTL">بيريميثامين (دواء يُستخدم غالبًا لعلاج الملاريا)</li></ul><p>&nbsp;</p><p dir="RTL">يمكن أيضًا استخدامها لعلاج تناول جرعة مفرطة من هذه الأدوية.</p><p>&nbsp;</p><p dir="RTL">يمكن استخدام حقن فولينات الكالسيوم أيضًا لزيادة فعالية دواء فلورويوراسيل المضاد للسرطان.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;يجب عدم استخدام حقن فولينات الكالسيوم داخل القراب (داخل العمود الفقري).</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>موانع استعمال حقن فولينات الكالسيوم</strong></p><ul><li dir="RTL">إذا ظهرت عليك في الماضي علامات الإصابة بفرط الحساسية (حساسية شديدة) تجاه فولينات الكالسيوم</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بنوع من فقر الدم ناتج عن الانخفاض الشديد في مستوى فيتامين ب<sub>۱۲</sub></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">أخبر طبيبك قبل استخدام هذا الدواء إذا كان أي من الحالتين المذكورتين أعلاه تنطبق عليك.</p><p>&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال حقن فولينات الكالسيوم</strong></p><p dir="RTL">إذا كان ينبغي أن تتلقى العلاج بفولينات الكالسيوم وفلورويوراسيل في نفس الوقت فتوخ الحذر بشكل خاص إذا:</p><ul><li dir="RTL">سبق أن خضعت للعلاج الإشعاعي</li><li dir="RTL">كنت تعاني من مشكلة في المعدة أو الأمعاء</li></ul><p>&nbsp;</p><p dir="RTL">أخبر طبيبك قبل استخدام هذا الدواء إذا كان أي من الحالتين المذكورتين أعلاه تنطبق عليك.</p><p>&nbsp;</p><p dir="RTL">يلزم توخي الحذر بشكل خاص أيضًا إذا كنت من المسنين وينبغي أن تتلقى العلاج بفولينات الكالسيوم وفلورويوراسيل في نفس الوقت.</p><p>&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">يلزم توخى الحذر بشكل خاص إذا كنت تتناول/تستخدم أدوية أخرى حيث إن بعضها قد يتفاعل مع حقن فولينات الكالسيوم، على سبيل المثال:</p><ul><li dir="RTL">&nbsp;مضادات حمض الفوليك (انظر القسم ۱ &quot;ما هي حقن فولينات الكالسيوم وما هي دواعي استعمالها&quot; لمعرفة أمثلة لهذه الأدوية) - سيقلل فولينات الكالسيوم من فعالية هذه الأدوية</li></ul><ul><li dir="RTL">فلورويوراسيل (دواء مضاد للسرطان) &ndash; سيزيد فولينات الكالسيوم من فعالية هذا الدواء وآثاره الجانبية</li><li dir="RTL">الأدوية التي تُستخدم لعلاج الصرع (فينوباربيتون، أو فينيتوين، أو بريميدون، أو السوكسينيميدات) &ndash; قد يقلل فولينات الكالسيوم من فعالية هذه الأدوية.&nbsp; قد يتحقق طبيبك من مستويات هذه الأدوية في دمك ويغير جرعتك لمنع زيادة الاختلاجات (النوبات)</li></ul><p>&nbsp;</p><p dir="RTL">يرجى إبلاغ طبيبك إذا كنت تتناول حاليًا أو قد تناولت مؤخرًا أي أدوية أخرى، بما في ذلك الأدوية التي يمكن الحصول عليها بدون وصفة طبية.</p><p>&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">أخبري طبيبكِ إذا كنتِ حاملًا أو تحاولين الحمل أو تُرضعين رضاعة طبيعية.</p><p>&nbsp;</p><p dir="RTL">&nbsp;من غير المحتمل أن يطلب منكِ طبيبكِ تناول/استخدام أحد مضادات حمض الفوليك أو فلورويوراسيل أثناء حملكِ أو أثناء فترة الرضاعة الطبيعية.&nbsp; بالرغم من ذلك، إذا تناولتِ/استخدمتِ أحد مضادات حمض الفوليك أثناء فترة الحمل أو الرضاعة الطبيعية، فقد يُستخدم هذا الدواء (فولينات الكالسيوم) لتقليل آثاره الجانبية.</p><p>&nbsp;</p><p dir="RTL">استشيري طبيبكِ أو الصيدلي قبل تناول أي أدوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحتوي حقن فولينات الكالسيوم على الصوديوم</strong></p><p>&nbsp;</p><p dir="RTL">يحتوي محلول فولينات الكالسيوم ٥۰ ملجم/٥ مل المخصص للحقن على ۷٤,۱٦ ملجم من الصوديوم (المكون الرئيسي لملح الطهي/الطعام) في كل قارورة بسعة ٥ مل. وهذا يعادل ۸,٠ ٪ من الحد الأقصى للمدخول الغذائي اليومي من الصوديوم الموصى به للبالغين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد يُعطى هذا الدواء عن طريق الحقن (باستخدام محقنة) في العضل. أو قد يُعطى عن طريق الحقن أو التسريب (التنقيط) في أحد الأوردة. إذا تم إعطاء حقن فولينات الكالسيوم عن طريق التسريب، فسيتم تخفيفها أولًا.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">سوف يحسب طبيبك الجرعة الصحيحة الملائمة لك من حقن فولينات الكالسيوم والمعدل الذي يجب إعطاؤها به.&nbsp; وسيعتمد ذلك على الحالة الطبية التي يتم علاجها.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا تلقيت كمية أكبر أو أقل مما ينبغي من حقن فولينات الكالسيوم</strong></p><p dir="RTL">&nbsp;سوف يُعطى لك هذا الدواء في مستشفى، وتحت إشراف طبيب.&nbsp; ومن غير المرجح أن يتم إعطاؤك كمية أكبر أو أقل مما ينبغي، ومع ذلك، أخبر طبيبك أو الممرضة إذا كانت لديك أي مخاوف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، يمكن أن تسبب حقن فولينات الكالسيوم أعراضًا جانبية، إلا أنها لا تصيب الجميع.</p><p dir="RTL"><br /><strong>&nbsp;نادرة جدًا: قد تصيب ما يصل إلى شخص واحد من بين كل ١٠٠٠٠ شخص</strong></p><ul><li dir="RTL">تفاعل حساسية شديد - قد تصاب بطفح جلدي مفاجئ مثير للحكة (شرى)، وتورم في اليدين، أو القدمين، أو الكاحلين، أو الوجه، أو الشفتين، أو الفم، أو الحلق (مما قد يسبب صعوبة في البلع أو التنفس)، وقد تشعر بأنك على وشك الإغماء. وهذا عرض جانبي خطير. فقد تحتاج إلى رعاية طبية عاجلة.</li></ul><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;غير شائعة: قد تصيب ما يصل إلى شخص واحد بين كل ۱۰۰ شخص</strong></p><ul><li dir="RTL">الحمى</li></ul><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>نادرة: قد تصيب ما يصل إلى شخص واحد من بين كل ۱۰۰۰ شخص</strong></p><ul><li dir="RTL">زيادة في الاختلاجات (النوبات) لدى المرضى المصابين بالصرع</li><li dir="RTL">الاكتئاب</li><li dir="RTL">التهيج</li><li dir="RTL">مشكلات بالجهاز الهضمي</li><li dir="RTL">صعوبة في النوم (الأرق)</li></ul><p>&nbsp;</p><p dir="RTL"><em>&nbsp;العلاج بالتزامن مع ٥-فلورويوراسيل فقط:</em></p><p dir="RTL">&nbsp;إذا تلقيت فولينات الكالسيوم بالتزامن مع دواء مضاد للسرطان يحتوي على الفلوروبيريميدينات، فقد تكون أكثر عرضة للإصابة بالأعراض الجانبية التالية لهذا الدواء الآخر:</p><p>&nbsp;</p><p dir="RTL"><strong>شائعة جدًا: قد تصيب أكثر من شخص واحد من بين كل ۱۰ أشخاص</strong></p><ul><li dir="RTL">الغثيان</li><li dir="RTL">القيء</li><li dir="RTL">الإسهال الشديد</li><li dir="RTL">الجفاف الذي قد يكون ناتجًا عن الإسهال</li><li dir="RTL">التهاب بطانة الأمعاء والفم (حدثت حالات مهددة للحياة)</li><li dir="RTL">انخفاض في عدد خلايا الدم (بما في ذلك حالات مهددة للحياة)</li></ul><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;شائعة:</strong><strong> قد تصيب ما يصل إلى شخص واحد من بين كل ۱۰ أشخاص</strong></p><ul><li dir="RTL">احمرار وتورم راحتي اليدين أو باطن القدمين قد يتسبب في تقشر الجلد (متلازمة اليد-القدم)</li><li dir="RTL">&nbsp;</li></ul><p dir="RTL"><strong>&nbsp;غير معروفة: لا يمكن تقدير معدل التكرار من البيانات المتاحة</strong></p><ul><li dir="RTL">ارتفاع مستوى الأمونيا في الدم</li></ul><p>&nbsp;</p><p dir="RTL">قد يجري طبيبك اختبارات لرصد انخفاض مستويات الكالسيوم في دمك.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا أصبت بأي أعراض جانبية، فتحدث إلى طبيبك، أو الصيدلي، أو الممرضة. يتضمن هذا أي أعراض جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الأعراض الجانبية مباشرةً عبر نظام الإبلاغ القومي. بالإبلاغ عن الأعراض الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p><strong>&nbsp;</strong></p><p dir="RTL">للإبلاغ عن الأعراض الجانبية</p><p>&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>&nbsp;المملكة العربية السعودية</strong></p><p><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي</strong></p><p dir="LTR">&nbsp;</p><ul><li dir="RTL">مركز الاتصال الموحد: ۱۹۹۹۹</li><li dir="RTL">&nbsp;البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><p>&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp; </em><em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;احتفظ بها بعيدًا عن متناول ومرأى الأطفال</p><p>&nbsp;</p><p dir="RTL"><strong>انتهاء الصلاحية</strong></p><p dir="RTL">يجب عدم استخدام هذا الدواء بعد مرور تاريخ انتهاء الصلاحية المدون على القارورة والعبوة الكرتونية بعد الرمز &quot;EXP&quot;.&nbsp; في حالة ذكر الشهر والعام فقط، فإن تاريخ انتهاء الصلاحية يشير إلى آخر يوم من الشهر المذكور.</p><p>&nbsp;</p><p dir="RTL"><strong>التخزين</strong></p><p dir="RTL">ينبغي تخزين القوارير في العبوة الكرتونية الخارجية في البراد (الثلاجة) لحمايتها من الضوء.</p><p>&nbsp;</p><p dir="RTL"><strong>علامات التلف الظاهرة</strong></p><p dir="RTL">ينبغي ألا تُستخدم سوى المحاليل الصافية ذات اللون الأصفر الفاتح. إذا كان شكل المحلول عكرًا أو يمكن رؤية جسيمات فيه، ينبغي التخلص منه.&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي حمض الفولينيك. &nbsp;يحتوي كل ملليلتر (مل) من المحلول على ١٠ مليجرامات (ملجم) من حمض الفولينيك في صورة هيدرات فولينات الكالسيوم.</p><p>&nbsp;</p><p dir="RTL">&nbsp;المكونات الأخرى هي كلوريد الصوديوم وماء للحقن. &nbsp;انظر القسم ٢ &quot;تحتوي حقن فولينات الكالسيوم على الصوديوم&quot; لمزيد من المعلومات حول المحتوى المتعلق بالصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">حقن فولينات الكالسيوم هي محلول صاف مخصص للحقن، لونه أصفر فاتح، ويتوفر في حاويات زجاجية تُسمى قوارير.</p><p style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">&nbsp;يتم توفير الدواء في عبوات تحتوي على:</p><ul><li dir="RTL" style="text-align: right;">قارورة واحدة سعة ٥٠ ملجم/٥ مل</li></ul><p style="text-align:right"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق:</strong><br />Hospira UK Ltd, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK، المملكة المتحدة</p><p>&nbsp;</p><p dir="RTL"><strong>المصنع</strong><strong>:</strong></p><p dir="RTL">Hospira Australia Pty Ltd 1-5, 7-23 and 25-39 Lexia Place MULGRAVE, VIC 3170, Australia</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مايو/أيار ٢٠٢٣
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Calcium Folinate 10 mg/ml Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial of 10 ml solution contains 10 mg/ml of folinic acid provided as calcium folinate hydrate.

Excipients with known effect:

Calcium folinate 50 mg/5 ml solution for injection contains 16.74 mg of sodium in each 5 ml of vial.

For excipients, see 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Calcium folinate is indicated</p><p>&nbsp;</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp; to diminish the toxicity and counteract the action of folic acid antagonists such as methotrexate in cytotoxic therapy and overdose in adults and children. In cytotoxic therapy, this procedure is commonly known as &ldquo;Calcium Folinate Rescue&rdquo;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp; in combination with 5-fluorouracil in cytotoxic therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For intravenous and intramuscular administration only. In the case of intravenous administration, no more than 160 mg of calcium folinate should be injected per minute due to the calcium content of the solution.</p><p>&nbsp;</p><p>For intravenous infusion, calcium folinate may be diluted with 0.9% sodium chloride solution or 5% glucose solution before use. Refer also to sections 6.3 and 6.6.</p><p>&nbsp;</p><p><em>Calcium folinate rescue in methotrexate therapy:</em></p><p>Since the calcium folinate rescue dosage regimen depends heavily on the posology and method of the intermediate- or high-dose methotrexate administration, the methotrexate protocol will dictate the dosage regimen of calcium folinate rescue. Therefore, it is best to refer to the applied intermediate or high dose methotrexate protocol for posology and method of administration of calcium folinate.</p><p>&nbsp;</p><p>The following guidelines may serve as an illustration of regimens used in adults, elderly and children:</p><p>&nbsp;</p><p><em>Calcium folinate rescue has to be performed by parenteral administration in patients with malabsorption syndromes or other gastrointestinal disorders where enteral absorption is not assured. Dosages above 25-50 mg should be given parenterally due to saturable enteral absorption of calcium folinate.</em></p><p>Calcium folinate rescue is necessary when methotrexate is given at doses exceeding 500 mg/m<sup>2</sup> body surface and should be considered with doses of 100 mg &ndash; 500 mg/m<sup>2</sup> body surface.&nbsp;</p><p>&nbsp;</p><p>Dosage and duration of calcium folinate rescue primarily depend on the type and dosage of methotrexate therapy, the occurrence of toxicity symptoms, and the individual excretion capacity for methotrexate. As a rule, the first dose of calcium folinate is 15 mg (6-12 mg/m&sup2;) to be given 12-24 hours (24 hours at the latest) after the beginning of methotrexate infusion. The same dose is given every 6 hours throughout a period of 72 hours. After several parenteral doses treatment can be switched over to the oral form.&nbsp;</p><p>&nbsp;</p><p>In addition to calcium folinate administration, measures to ensure the prompt excretion of methotrexate (maintenance of high urine output and alkalinisation of urine) are integral parts of the calcium folinate rescue treatment. Renal function should be monitored through daily measurements of serum creatinine.&nbsp;</p><p>&nbsp;</p><p>Forty-eight hours after the start of the methotrexate infusion, the residual methotrexate-level should be measured. If the residual methotrexate-level is &gt;0.5 &micro;mol/l, calcium folinate dosages should be adapted according to the following table:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Residual methotrexate blood level 48 hours after the start of the methotrexate administration:</p></td><td style="vertical-align:top"><p>Additional calcium folinate to be administered every 6 hours for 48 hours or until levels of methotrexate are lower than 0.05 &micro;mol/l:</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 0.5 &micro;mol/l</p></td><td style="vertical-align:top"><p>15 mg/m&sup2;</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 1.0 &micro;mol/l</p></td><td style="vertical-align:top"><p>100 mg/m&sup2;</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 2.0 &micro;mol/l</p></td><td style="vertical-align:top"><p>200 mg/m&sup2;</p></td></tr></tbody></table><p>&nbsp;</p><p><em>In combination with 5-fluorouracil in cytotoxic therapy:</em></p><p>Different regimens and different dosages are used, without any dosage having been proven to be the optimal one.&nbsp;</p><p>&nbsp;</p><p>The following regimens have been used in adults and elderly in the treatment of advanced or metastatic colorectal cancer and are given as examples. There are no data on the use of these combinations in children:</p><p>&nbsp;</p><p><u>Bimonthly regimen</u>: Calcium folinate 200 mg/m<sup>2</sup> by intravenous infusion over two hours, followed by bolus 400 mg/m<sup>2</sup> of 5-FU and 22-hour infusion of 5-FU (600 mg/m<sup>2</sup>) for 2 consecutive days, every 2 weeks on days 1 and 2.</p><p>&nbsp;</p><p><u>Weekly regimen</u>: Calcium folinate 20 mg/m&sup2; by bolus i.v. injection or 200 to 500 mg/m&sup2; as i.v. infusion over a period of 2 hours plus 500 mg/m&sup2; 5-fluorouracil as i.v. bolus injection in the middle or at the end of the calcium folinate infusion.</p><p>&nbsp;</p><p><u>Monthly regimen</u>: Calcium folinate 20 mg/m&sup2; by bolus i.v. injection or 200 to 500 mg/m&sup2; as i.v. infusion over a period of 2 hours immediately followed by 425 or 370 mg/m&sup2; 5-fluorouracil as i.v. bolus injection during five consecutive days.</p><p>&nbsp;</p><p>For the combination therapy with 5-fluorouracil, modification of the 5-fluorouracil dosage and the treatment-free interval may be necessary depending on patient condition, clinical response and dose limiting toxicity as stated in the product information of 5-fluorouracil. A reduction of calcium folinate dosage is not required.</p><p>The number of repeat cycles used is at the discretion of the clinician.</p><p>&nbsp;</p><p><em>Antidote to the folic acid antagonists trimetrexate, trimethoprim, and pyrimethamine:</em></p><p><em>&nbsp;</em></p><p>Trimetrexate toxicity:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prevention: Calcium folinate should be administered every day during treatment with trimetrexate and for 72 hours after the last dose of trimetrexate. Calcium folinate can be administered either by the intravenous route at a dose of 20 mg/m&sup2; for 5 to 10 minutes every 6 hours for a total daily dose of 80 mg/m&sup2;, or by oral route with four doses of 20 mg/m<sup>2</sup> administered at equal time intervals. Daily doses of calcium folinate should be adjusted depending on the haematological toxicity of trimetrexate.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overdosage (possibly occurring with trimetrexate doses above 90 mg/m<sup>2</sup> without concomitant administration of calcium folinate): after stopping trimetrexate, calcium folinate 40 mg/m<sup>2</sup> IV every 6 hours for 3 days.</p><p>&nbsp;</p><p>Trimethoprim toxicity:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After stopping trimethoprim, 3-10 mg/day calcium folinate until recovery of a normal blood count.</p><p>&nbsp;</p><p>Pyrimethamine toxicity:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of high dose pyrimethamine or prolonged treatment with low doses, calcium folinate 5 to 50 mg/day should be simultaneously administered, based on the results of the peripheral blood counts.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Known hypersensitivity to calcium folinate, or to any of the excipients.
•	Pernicious anaemia or other anaemias due to vitamin B12 deficiency.

Regarding the use of calcium folinate with methotrexate or 5-fluorouracil during pregnancy and lactation, see section 4.6, “Pregnancy and Lactation” and the summaries of product characteristics for methotrexate- and 5-fluorouracil- containing medicinal products.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Calcium folinate should only be given by intramuscular or intravenous injection and must not be administered intrathecally.&nbsp; </strong>When folinic acid has been administered intrathecally following intrathecal overdose of methotrexate death has been reported.</p><p>&nbsp;</p><p><em>General</em></p><p>&nbsp;</p><p>Calcium folinate should be used with methotrexate or 5-fluorouracil only under the direct supervision of a clinician experienced in the use of cancer chemotherapeutic agents.&nbsp;</p><p>&nbsp;</p><p>Calcium folinate treatment may mask pernicious anaemia and other anaemias resulting from vitamin B12 deficiency.</p><p>&nbsp;</p><p>Many cytotoxic medicinal products &ndash; direct or indirect DNA synthesis inhibitors &ndash; lead to macrocytosis (hydroxycarbamide, cytarabine, mecaptopurine, thioguanine). Such macrocytosis should not be treated with folinic acid.</p><p>&nbsp;</p><p>In epileptic patients treated with phenobarbital, phenytoin, primidone, and succinimides there is a risk to increase the frequency of seizures due to a decrease of plasma concentrations of anti-epileptic drugs. Clinical monitoring, possibly monitoring of the plasma concentrations and, if necessary, dose adaptation of the anti-epileptic drug during calcium folinate administration and after discontinuation is recommended (see also section 4.5 Interactions).</p><p>&nbsp;</p><p><em>Calcium folinate/5-fluorouracil</em></p><p><em>&nbsp;</em></p><p>Calcium folinate may enhance the toxicity risk of 5-fluorouracil, particularly in elderly or debilitated patients. The most common manifestations are leucopenia, mucositis, stomatitis and/or diarrhoea, which may be dose limiting. When calcium folinate and 5-fluorouracil are used in combination, the 5- fluorouracil dosage has to be reduced more in cases of toxicity than when 5-fluorouracil is used alone.</p><p>&nbsp;</p><p>Combined 5-fluorouracil/calcium folinate treatment should neither be initiated nor maintained in patients with symptoms of gastrointestinal toxicity, regardless of the severity, until all of these symptoms have completely disappeared.</p><p>&nbsp;</p><p>Because diarrhoea may be a sign of gastrointestinal toxicity, patients presenting with diarrhoea must be carefully monitored until the symptoms have disappeared completely, since a rapid clinical deterioration leading to death can occur. If diarrhoea and/or stomatitis occur, it is advisable to reduce the dose of 5-FU until symptoms have fully disappeared. Especially the elderly and patients with a low physical performance due to their illness are prone to these toxicities. Therefore, particular care should be taken when treating these patients.</p><p>&nbsp;</p><p>In elderly patients and patients who have undergone preliminary radiotherapy, it is recommended to begin with a reduced dosage of 5-fluorouracil.</p><p>&nbsp;</p><p>Calcium folinate must not be mixed with 5-fluorouracil in the same IV injection or infusion.</p><p>&nbsp;</p><p>Calcium levels should be monitored in patients receiving combined 5-fluorouracil/calcium folinate treatment and calcium supplementation should be provided if calcium levels are low.</p><p>&nbsp;</p><p><em>Calcium folinate/methotrexate</em></p><p><em>&nbsp;</em></p><p>For specific details on reduction of methotrexate toxicity refer to the SPC of methotrexate.</p><p>&nbsp;</p><p>Calcium folinate has no effect on non-haematological toxicities of methotrexate such as the nephrotoxicity resulting from methotrexate and/or metabolite precipitation in the kidney. Patients who experience delayed early methotrexate elimination are likely to develop reversible renal failure and all toxicities associated with methotrexate (please refer to the SPC for methotrexate). &nbsp;The presence of pre-existing or methotrexate-induced renal insufficiency is potentially associated with delayed excretion of methotrexate and may increase the need for higher doses or more prolonged use of calcium folinate.</p><p>Excessive calcium folinate doses must be avoided since this might impair the antitumour activity of methotrexate, especially in CNS tumours where calcium folinate accumulates after repeated courses.</p><p>&nbsp;</p><p>Resistance to methotrexate as a result of decreased membrane transport implies also resistance to folinic acid rescue as both medicinal products share the same transport system.</p><p>&nbsp;</p><p>An accidental overdose with a folate antagonist, such as methotrexate, should be treated as a medical emergency. As the time interval between methotrexate administration and calcium folinate rescue increases, calcium folinate effectiveness in counteracting toxicity decreases.&nbsp;</p><p>&nbsp;</p><p>The possibility that the patient is taking other medications that interact with methotrexate (eg, medications which may interfere with methotrexate elimination or binding to serum albumin) should always be considered when laboratory abnormalities or clinical toxicities are observed.</p><p>&nbsp;</p><p><u>Excipient information</u></p><p>Calcium folinate 50 mg/5 ml solution for injection contains 16.74 mg of sodium per 5 ml vial, equivalent to 0.8% of the WHO recommended maximum daily intake of 2 g sodium for an adult.</p><p>&nbsp;</p><p>Calcium folinate 100 mg/10 ml solution for injection contains 33.5 mg of sodium in each 10 ml vial, equivalent to 1.7% of the WHO recommended maximum daily intake of 2 g sodium for an adult.</p><p>&nbsp;</p><p>Calcium folinate 300 mg/30 ml solution for injection contains 100.5 mg sodium in each 30 ml vial, equivalent to 5% of the WHO recommended maximum daily intake of 2 g sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When calcium folinate is given in conjunction with a folic acid antagonist (e.g. cotrimoxazole, pyrimethamine) the efficacy of the folic acid antagonist may either be reduced or completely neutralised.</p><p>&nbsp;</p><p>Calcium folinate may diminish the effect of anti-epileptic substances: phenobarbital, primidone, phenytoin and succinimides, and may increase the frequency of seizures (a decrease of plasma levels of enzymatic inductor anticonvulsant drugs may be observed because the hepatic metabolism is increased as folates are one of the cofactors) (see also sections 4.4 and 4.8).</p><p>&nbsp;</p><p>Concomitant administration of calcium folinate with 5-fluorouracil has been shown to enhance the efficacy and toxicity of 5-fluorouracil (see sections 4.2, 4.4 and 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no adequate and well-controlled clinical studies conducted in pregnant or breast-feeding women. Animal studies are insufficient with respect to reproductive toxicity (see section 5.3). However, there are no indications that folic acid induces harmful effects if administered during pregnancy. During pregnancy, methotrexate should only be administered on strict indications, where the benefits of the drug to the mother should be weighed against possible hazards to the foetus. Should treatment with methotrexate or other folate antagonists take place despite pregnancy or lactation, there are no limitations as to the use of calcium folinate to diminish toxicity or counteract the effects.</p><p>&nbsp;</p><p>5-fluorouracil use is generally contraindicated during pregnancy and contraindicated during breastfeeding; this applies also to the combined use of calcium folinate with 5-fluorouracil.</p><p>&nbsp;</p><p>Please refer also to the summaries of product characteristics for methotrexate-, other folate antagonists and 5-fluorouracil- containing medicinal products.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether calcium folinate is excreted into human breast milk. Calcium folinate can be used during breast feeding when considered necessary according to the therapeutic indications.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Calcium folinate is an intermediate product in the metabolism of folic acid and occurs naturally in the body. No fertility studies have been conducted with calcium folinate in animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no evidence that calcium folinate has an effect on the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequencies are defined using the following convention:</p><p>Very common (&ge;1/10);</p><p>common (&ge;1/100 to &lt;1/10);</p><p>uncommon (&ge;1/1,000 to &lt;1/100);</p><p>rare (&ge;1/10,000 to &lt;1/1,000);</p><p>very rare (&lt;1/10,000);</p><p>not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p>Immune system disorders</p><p><em>Very rare (&lt;0.01%): allergic reactions, including anaphylactoid/ anaphylactic reactions and urticaria.</em></p><p><em>&nbsp;</em></p><p>Psychiatric disorders</p><p><em>Rare (0.01-0.1%): insomnia, agitation and depression after high doses.</em></p><p>&nbsp;</p><p>Gastrointestinal disorders</p><p><em>Rare (0.01-0.1%): gastrointestinal disorders after high doses.</em></p><p>&nbsp;</p><p>Neurological disorders</p><p><em>Rare (0.01-0.1%): increase in the frequency of attacks in epileptics (see also section 4.5</em></p><p><em>Interactions...).</em></p><p>&nbsp;</p><p>General disorders and administration site conditions</p><p>Uncommon (0.1-1%): fever has been observed after administration of calcium folinate as solution for injection.</p><p>&nbsp;</p><p><em>Combination therapy with 5-fluorouracil only:</em></p><p>Generally, the safety profile depends on the applied regimen of 5-fluorouracil due to enhancement of the 5-fluorouracil induced toxicities:</p><p>&nbsp;</p><p><u>Metabolism and Nutritional Disorder</u>:</p><p>Not known: Hyperammonaemia</p><p>&nbsp;</p><p><u>Blood and lymphatic system disorders</u>:</p><p>Very common: bone marrow failure, including fatal cases</p><p>&nbsp;</p><p>General disorders and administration site conditions</p><p>Very common (&gt;10%): &nbsp;mucositis, including stomatitis and chelitis. Fatalities have occurred as a result of mucositis</p><p>&nbsp;</p><p><u>Skin and subcutaneous tissue disorders</u>:</p><p>Common: Palmar-Plantar Erythrodysaesthesia</p><p>&nbsp;</p><p><u>Monthly regimen</u>:</p><p><u>Gastrointestinal disorders</u></p><p>Very common (&gt;10%): vomiting and nausea</p><p>&nbsp;</p><p>No enhancement of other 5-fluorouracil induced toxicities (e.g. neurotoxicity).</p><p>&nbsp;</p><p><u>Weekly regimen</u>:</p><p>Gastrointestinal disorders</p><p>Very common (&gt;10%): diarrhoea with higher grades of toxicity, and dehydration, resulting in hospital admission for treatment and even death.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local country requirements.</p><p>&nbsp;</p><p>To Report side effects</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi</strong><strong> Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There have been no reported sequelae in patients who have received significantly more calcium folinate than the recommended dosage. However, excessive amounts of calcium folinate may nullify the chemotherapeutic effect of folic acid antagonists.</p><p>&nbsp;</p><p>Should overdosage of the combination of 5-fluorouracil and calcium folinate occur, the overdosage instructions for 5-FU should be followed.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Detoxifying agents for antineoplastic treatment; ATC code: V03AF03</p><p>&nbsp;</p><p>Calcium folinate is the calcium salt of 5-formyl tetrahydrofolic acid. It is an active metabolite of folinic acid and an essential coenzyme for nucleic acid synthesis in cytotoxic therapy.</p><p>&nbsp;</p><p>Calcium folinate is frequently used to diminish the toxicity and counteract the action of folate antagonists, such as methotrexate. Calcium folinate and folate antagonists share the same membrane transport carrier and compete for transport into cells, stimulating folate antagonist efflux. It also protects cells from the effects of folate antagonist by repletion of the reduce folate pool. Calcium folinate serves as a pre-reduced source of H4 folate; it can therefore bypass folate antagonist blockage and provide a source for the various coenzyme forms of folic acid.</p><p>&nbsp;</p><p>Calcium folinate is also frequently used in the biochemical modulation of fluoropyridine (5-FU) to enhance its cytotoxic activity. 5-FU inhibits thymidylate synthase (TS), a key enzyme involved in pyrimidine biosynthesis, and calcium folinate enhances TS inhibition by increasing the intracellular folate pool, thus stabilising the 5FU-TS complex and increasing activity.</p><p>&nbsp;</p><p>Finally intravenous calcium folinate can be administered for the prevention and treatment of folate deficiency when it cannot be prevented or corrected by the administration of folic acid by the oral route. This may be the case during total parenteral nutrition and severe malabsorption disorders. It is also indicated for the treatment of megaloblastic anaemia due to folic acid deficiency, when oral administration is not feasible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Following intramuscular administration of the aqueous solution, systemic availability is comparable to an intravenous administration. However, lower peak serum levels (Cmax) are achieved.</p><p>&nbsp;</p><p><u>Metabolism</u></p><p>Calcium folinate is a racemate where the L-form (L-5-formyl-tetrahydrofolate, L-5-formyl-THF), is the active enantiomer.&nbsp; The major metabolic product of folinic acid is 5-methyl-tetrahydrofolic acid (5-methyl-THF) which is predominantly produced in the liver and intestinal mucosa.</p><p>&nbsp;</p><p><u>Distribution</u></p><p>The distribution volume of folinic acid is not known.</p><p>Peak serum levels of the parent substance (D/L-5-formyl-tetrahydrofolic acid, folinic acid) are reached 10 minutes after i.v. administration.&nbsp;</p><p>&nbsp;</p><p>AUC for L-5-formyl-THF and 5-methyl<strong><em>-</em></strong>THF were 28.4&plusmn;3.5 mg.min/l and 129&plusmn;112 mg.min/l after a dose of 25 mg. The inactive D-isomer is present in higher concentration than L-5-formyltetrahydrofolate.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The elimination half-life is 32 - 35 minutes for the active L-form and 352 - 485 minutes for the inactive D-form, respectively.</p><p>&nbsp;</p><p>The total terminal half-life of the active metabolites is about 6 hours (after intravenous and intramuscular administration).</p><p>&nbsp;</p><p><u>Excretion</u></p><p>80-90 % with the urine (5- and 10-formyl-tetrahydrofolates inactive metabolites), 5-8 % with the faeces.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Genotoxicity, carcinogenicity and fertility studies have not been conducted with calcium folinate.</p><p>&nbsp;</p><p>Embryo-foetal reproduction toxicity studies have been performed in rats and rabbits. Rats were dosed up to 1800 mg/m<sup>2</sup> which is 9 times the maximum recommended human dose, and rabbits were dosed up to 3300 mg/m<sup>2</sup> which is 16 times the maximum recommended human dose. There was no embryo‑foetal toxicity noted in rats. At the maximum dose in rabbits, there was an increase in early embryonic resorptions and no other adverse effects on embryo-foetal development. No resorptions were noted in dose groups at 5 times the maximum recommended human dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride</p><p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibilities have been reported between injectable forms of calcium folinate and injectable forms of droperidol, fluorouracil, foscarnet and methotrexate.</p><p>&nbsp;</p><p><strong>Droperidol</strong></p><p>1. Droperidol 1.25 mg/0.5 ml with calcium folinate 5 mg/0.5 ml, immediate precipitation in direct admixture in syringe for 5 minutes at 25&deg; C followed by 8 minutes of centrifugation.</p><p>2. Droperidol 2.5 mg/0.5 ml with calcium folinate 10 mg/0.5 ml, immediate precipitation when the drugs were injected sequentially into a Y-site without flushing the Y-side arm between injections.</p><p>&nbsp;</p><p><strong>Fluorouracil</strong></p><p>Calcium folinate must not be mixed in the same infusion as 5-fluorouracil because a precipitate may form. Fluorouracil 50 mg/ml with calcium folinate 20 mg/ml, with or without dextrose 5% in water, has been shown to be incompatible when mixed in different amounts and stored at 4&deg;C, 23&deg;C, or 32&deg; C in polyvinyl chloride containers.</p><p>&nbsp;</p><p><strong>Foscarnet</strong></p><p>Foscarnet 24 mg/ml with calcium folinate 20 mg/ml formation of a cloudy yellow solution reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Product as packaged for sale: 24 months.

In use: From a microbial point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally mot be longer than 24 hours at 2 to 8C.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (+2&deg;C to +8&deg;C)</p><p>&nbsp;</p><p>Keep vial in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 mL Type I glass vials (50 mg/5 mL)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prior to administration, calcium folinate should be inspected visually. The solution for injection or infusion should be a clear and yellowish solution. If cloudy in appearance or particles are observed, the solution should be discarded. Calcium folinate solution for injection or infusion is intended only for single use. Any unused portion of the solution should be disposed of in accordance with the local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing authorization holder:
Hospira UK Ltd, 
Horizon, 
Honey Lane, 
Hurley, 
Maidenhead, 
SL6 6RJ, 
UK

Manufacturer:
Hospira Australia Pty Ltd 1-5, 7-23 and 25-39 Lexia Place MULGRAVE, VIC 3170, Australia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>